The minimal change in other effects, combined with the overall slight model performance improvement (AUROC from 0.84 to 0.86), indicates that while CRP refines risk prediction for certain subgroups, particularly in the context of suspected infections, the core mortality predictors remain unchanged. This evidence concerns the gene CRP and infection.